Search Results for: NF2

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
DCAF1 DDB1 and CUL4 associated factor 1
  • Antigen processing: Ubiquitination & Proteasome degradation
LATS1 large tumor suppressor kinase 1
  • Signaling by Hippo
  • Fostamatinib
LATS2 large tumor suppressor kinase 2
  • Signaling by Hippo
MAP2K5 mitogen-activated protein kinase kinase 5
  • Signalling to ERK5
  • Fostamatinib
MYBPC2 myosin binding protein C2
  • Striated Muscle Contraction
SOX3 SRY-box transcription factor 3
  • Deactivation of the beta-catenin transactivating complex
  • Septo-optic dysplasia
  • Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defects (SSPD); Insulin-like growth factor 1 deficiency (IGFD)
  • 46,XX disorders of sex development (Disorders of gonadal development), including: Ovotesticular DSD; Testicular DSD; Ovarian dysgenesis
  • Syndromic X-linked mental retardation, including: Turner type (MRXST); Siderius type (MRXSSD) ; Cabezas type (MRXC); Raymond type (MRXSR); Type10 (MRXS10); Type14 (MRXS14); Mental retardation with isolated growth hormone deficiency (MRGH)
SOX4 SRY-box transcription factor 4
  • Deactivation of the beta-catenin transactivating complex
TTYH2 tweety family member 2
  • Stimuli-sensing channels
AMOT angiomotin
CBLC Cbl proto-oncogene C
CCNB1IP1 cyclin B1 interacting protein 1
DACH1 dachshund family transcription factor 1
GLIS2 GLIS family zinc finger 2
  • Nephronophthisis-medullary cystic kidney disease, including; Nephronophthisis (NPH) ; Nephronophthisis-like nephropathy 1; Medullary cystic kidney disease 1; Medullary cystic kidney disease 2 (MSKD2)
RASSF1 Ras association domain family member 1
  • Non-small cell lung cancer
  • Bladder cancer
  • Nasopharyngeal cancer
SCHIP1 schwannomin interacting protein 1
SGSM3 small G protein signaling modulator 3
SLC9A3R1 SLC9A3 regulator 1
  • Nephrolithiasis/osteoporosis, hypophosphatemic
TXLNB taxilin beta

Page 4 out of 4 pages